Europe — EMA
Morfina Basi (Morphine)
GNH USA supplies Morfina Basi (Morphine), an opioid analgesic for severe acute, post‑operative and cancer‑related pain. Request a quote for global supply.
Request sourcing
What is Morphine?
Morphine, the active ingredient in Morfina Basi, is an opioid analgesic presented as an injectable solution for intravenous or subcutaneous use. It treats severe acute pain, post‑operative pain and cancer‑related pain in adult patients.
GNH USA supplies Morfina Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Morphine used for?
Morphine is an opioid analgesic used in the management of severe pain.
- Severe acute pain: provides rapid relief of intense, short‑term pain. - Post‑operative pain: controls discomfort following surgical procedures. - Cancer‑related pain: alleviates chronic malignant pain and improves quality of life.
What are the side effects of Morphine?
Morphine may cause a range of adverse reactions that vary in frequency and severity.
Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Itching or pruritus - Sweating - Dry mouth
Serious or Rare Side Effects: - Respiratory depression - Severe hypotension or cardiovascular collapse - Bradycardia - Seizures - Anaphylactic or severe allergic reactions - Adrenal insufficiency
What precautions apply to Morphine?
When using Morfina Basi, clinicians should observe several safety measures.
- Assess pain severity: determine appropriate dosing based on individual needs. - Monitor respiratory function: watch for signs of depression, especially after dose adjustments. - Evaluate renal and hepatic function: adjust dosing in impairment. - Avoid concurrent CNS depressants: increased risk of sedation and respiratory compromise. - Use caution in elderly patients: heightened sensitivity to opioid effects. - Store at ambient temperature: keep in original container, protect from moisture and light.
What does Morphine interact with?
Morphine can interact with other medicines, requiring careful management.
Major Interactions (Avoid): - Other opioids: additive risk of respiratory depression. - Benzodiazepines or barbiturates: enhanced sedation and respiratory suppression. - Monoamine oxidase inhibitors (MAOIs): potential for serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increased morphine plasma levels. - CNS depressant antihistamines: heightened drowsiness.
Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced analgesic effect. - Diuretics: may exacerbate hypotension. - Anticholinergic agents: worsen constipation. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal bleeding. - Alcohol: additive central nervous system depression.



